Lincomycin hydrochloride (often called lincomycin HCl) is an aminocyclitol antibiotic that is produced through a fermentation‑based process. While Pfizer is one of the companies that markets lincomycin products, the actual active pharmaceutical ingredient (API) is typically supplied by specialized contract manufacturers rather than by Pfizer’s own facilities. Here’s a quick overview of the common API suppliers that have been known to provide lincomycin HCl to major pharmaceutical companies (including those that manufacture Pfizer‑branded formulations):
| Typical API Supplier | Key Information |
|--------------------------|---------------------|
| BASF (Germany) | Historically supplied lincomycin HCl for European and US markets; has a robust fermentation platform. |
| Bayer AG (Germany) | Offers lincomycin HCl under contract‑manufacturing agreements; also produces the final drug product for some brands. |
| Tianjin Huaneng Pharmaceutical Co., Ltd. (China) | Large contract‑manufacturing provider of lincomycin HCl for both domestic and international markets. |
| Sinopharm Chemical (China) | Provides lincomycin HCl API to various global manufacturers; known for high‑purity production. |
| Shandong Jiangsu Huayi Pharmaceutical Co., Ltd. (China) | Supplies lincomycin HCl to several multinational brands. |
| Hetero Labs Ltd. (India) | Contract manufacturer for lincomycin HCl used by various global pharma companies. |
How the Process Works
1. Fermentation – The lincomycin‑producing bacterial strain (usually Streptomyces lincolnensis or S. lincolnensis subsp. lincolni) is cultivated in a controlled, nutrient‑rich medium.
2. Extraction & Purification – The antibiotic is extracted from the broth, then purified via chromatography or crystallization to reach API‑grade purity (typically >99%).
3. Formulation – Once the API is delivered to the drug manufacturer (e.g., Pfizer), it’s blended with excipients to create the final dosage form (tablets, capsules, injections).
Why Pfizer Might Not Be the API Manufacturer
- Scale & Expertise: Pfizer’s core strengths lie in formulation, clinical development, and commercial distribution. The fermentation of lincomycin is highly specialized and often more cost‑effective when outsourced to firms with dedicated microbial production lines.
- Regulatory Efficiency: Contract manufacturers that specialize in antibiotic APIs already hold GMP certifications tailored to microbial products, speeding up the regulatory pathway.
- Supply Chain Flexibility: By sourcing from multiple API suppliers, Pfizer can mitigate risks such as raw‑material shortages, batch variability, or regional disruptions.
Finding the Exact Supplier
If you need the definitive API source for a specific Pfizer lincomycin product (e.g., a particular dosage strength or formulation), the best route is:
1. Check the drug’s package insert – Many generic manufacturers list the API supplier in the “Manufactured By” section.
2. Contact Pfizer’s customer service – They can confirm the current API partner for that product line.
3. Review FDA/EMA submission documents – These often contain the “Manufacturer’s Address” and “API Source” details in the drug master file.
---
Bottom line: Pfizer typically contracts with specialized API manufacturers—often from Germany or China—to obtain lincomycin hydrochloride for its products. The specific supplier can vary over time, so contacting Pfizer directly or reviewing the product’s regulatory filings will give you the most up‑to‑date information.